AI MARKET SCANNING

Pacira BioSciences, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP +0.30%
MAX GAP RECORD +13.56%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PCRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
-5.65%
Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE)
+5.53%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
-6.42%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-3.70%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
-1.29%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-0.64%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+2.44%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
-0.51%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.0%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PCRX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗